Saying Goodbye to Albert Ellis: 1913 - 2007
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
“The trouble with most therapy is that it helps you feel better,” Albert Ellis told The New York Times in an interview in 2004. “But you don’t get better. You have to back it up with action, action, action.” This legend recently died – what did legacy he leave us? Joining Dr. Leslie Lundt is Arthur Freeman, Ed.D. who worked with Dr. Ellis in New York for more than 30 years and new him as a student, then colleague and close friend and associate.
Overview
“The trouble with most therapy is that it helps you feel better,” Albert Ellis told The New York Times in an interview in 2004. “But you don’t get better. You have to back it up with action, action, action.” This legend recently died – what did legacy he leave us? Joining Dr. Leslie Lundt is Arthur Freeman, Ed.D. who worked with Dr. Ellis in New York for more than 30 years and new him as a student, then colleague and close friend and associate.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Updates From the 7th World Symposium Task Force
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Diagnosis and Management of Metastatic PDAC
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?